Goldgroup Mining Inc. ("Goldgroup" or the "Company") (TSX:GGA) (OTC:GGAZF) (BMV SIX:GGAN.MX) is pleased to announce that the Company has produced 285 ounces of gold from the initial gold production in December 2013 from its Cerro Prieto ...
Tags: Goldgroup, initial gold production, Cerro Prieto heap-leach mine, gold
Applying technologies originally developed for high technology government programs to our national energy and economic priorities, Lockheed Martin [NYSE: LMT] is leveraging its expertise in the manufacture of Space Shuttle external tanks to ...
Under Zion's Asher-Menashe License, the Company is required to perform a perforation and stimulation operation at the Elijah #3 well and conduct a production test. We plan to perforate the zone of interest, fluid stimulate the zone, and ...
Tags: Elijah#3 well, Zion, Asher-Menashe License, drill stem test
Friday, Jan 10, 2014 Foran Mining Corporation (TSX VENTURE:FOM) ("Foran" or the "Company") is pleased to announce that it has reached an agreement (the "Agreement") with Thundermin Resources Inc. ("Thundermin") to purchase the net profits ...
Tags: Foran, Thundermin, net profits interest, purchase shares
Europe's largest coking coal producer Poland-based Jastrzebska Spolka Weglowa SA (JSW) has announced that it has established a new coke subsidiary JSW Koks SA, based in Zabrze in Silesia in southern Poland, in which it has a 95.71 percent ...
Tags: coking coal, steel, Metallurgy, Mineral
Evolva Holding SA (SIX:EVE) has appointed BNY Mellon, the global leader in investment management and investment services, to set up a Level-1 American Depositary Receipt (ADR) programme. Each Evolva ADR will represent 10 ordinary shares ...
Tags: Evolva, BNY Mellon, Level-1 American Depositary Receipt, Evolva ADR
AccentHealth, the leading patient education company at the Point-of-Care, announced today it has purchased the Asthma and Allergy waiting room television network of Caervision Corp. The new doctor office locations will become part of the ...
Tags: AccentHealth, Caervision
Mylan, Inc. (Nasdaq: MYL) today announced that Zyomyx's MyT4™ point-of-care CD4 diagnostic test has received the CE Certificate of Conformity in the European Union, an important step toward launching this innovative test and expanding ...
Tags: Mylan, Zyomyx's MyT4™point-of-care CD4, diagnostic test, HIV
Biogen Idec (NASDAQ: BIIB) and Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that ...
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) recently approved ISENTRESS® for oral suspension, a new pediatric formulation of Merck's integrase ...
Tags: Merck, ISENTRESS®, oral suspension, pediatric formulation
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center ...
Tags: Trevena, GPCR biased ligands, BLAST-AHF, acute heart failure
EMS provider Lite-On Technology has reported consolidated revenues of NT$20.182 billion (US$673 million) for December, increasing 2.97% sequentially and 16.07% on year. Fourth-quarter 2013 consolidated revenues reached NT$59.231 billion, ...
Tags: Lite-on Technology, Lighting
Satellite Logistics Group (SLG), a leading supply-chain solution provider for the beverage industry, has named MindShare Strategies its marketing agency of record. A marketing firm specializing in the transportation and logistics ...
Tags: Beverage Logistics, Food
Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic® ...
Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, related to the use of Illumina's ...
Tags: Illumina, multi-year licensing agreement, Quest Diagnostics